Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-002907

Chief Financial Officer acquired 354,296 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bodenstedt Matthias Chief Financial Officer 2026-01-07 Grant or award +354,296 1,276,305 D: show line 1 in the form
Loading xslF345X05/ownership.xml…